The primary role of EGFR activation in breast cancer cells is to stimulate exercise, and it has been demonstrated for the first time that maintaining the ability of EGFR cell surface expression through ACK1 can enhance the invasion ability of breast cancer cells. This evidence concerns the gene TNK2 and breast cancer.